Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

<p><strong>Background</strong> There have been no studies of the patterns of post-marketing withdrawals of medicinal products to which adverse reactions have been attributed. We identified medicinal products that were withdrawn because of adverse drug reactions, examined the eviden...

Полное описание

Библиографические подробности
Главные авторы:	Onakpoya, IJ, Heneghan, CJ, Aronson, JK
Формат:	Journal article
Язык:	English
Опубликовано:	BioMed Central 2016

Схожие документы

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
по: Igho J. Onakpoya, и др.
Опубликовано: (2019-03-01)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
по: Onakpoya, I, и др.
Опубликовано: (2016)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
по: Onakpoya, I, и др.
Опубликовано: (2017)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
по: Onakpoya, I, и др.
Опубликовано: (2016)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
по: Onakpoya, I, и др.
Опубликовано: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
по: Onakpoya, I
Опубликовано: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
по: Onakpoya, I, и др.
Опубликовано: (2017)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
по: Onakpoya, IJ, и др.
Опубликовано: (2020)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
по: Daniele Sartori, и др.
Опубликовано: (2020-08-01)

Withdrawal of cerivastatin from the world market
по: Pitt Bertram, и др.
Опубликовано: (2001-09-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
по: Onakpoya, I, и др.
Опубликовано: (2018)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
по: Aronson, J
Опубликовано: (2017)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
по: Aronson, J
Опубликовано: (2008)

Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update
по: Jefferson, T, и др.
Опубликовано: (2022)

An agenda for research on adverse drug reactions.
по: Aronson, J
Опубликовано: (2007)

Adverse drug reactions--no farewell to harms.
по: Aronson, J
Опубликовано: (2007)

Pharmacogenetics and adverse drug reactions
по: Ferner, R, и др.
Опубликовано: (2010)

REG 462 - Rekabentuk Konkrit
по: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Опубликовано: (1995)

Withdrawn medicines included in the essential medicines lists of 136 countries.
по: Onella Charles, и др.
Опубликовано: (2019-01-01)

Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: a systematic review
по: Salas-Gama, K, и др.
Опубликовано: (2022)

20.462J / 3.962J Molecular Principles of Biomaterials (BE.462J), Spring 2003
по: Irvine, Darrell J.
Опубликовано: (2003)

The effectiveness and safety of Japanese traditional medicine (Kampo) in the treatment of climacteric symptoms
по: Onakpoya, I, и др.
Опубликовано: (2013)

Adverse drug reactions: definitions, diagnosis, and management.
по: Edwards, I, и др.
Опубликовано: (2000)

What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries
по: Coombs, C, и др.
Опубликовано: (2017)

Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity
по: Ferner, RE, и др.
Опубликовано: (2022)

Adverse drug reactions: keeping up to date.
по: Aronson, J, и др.
Опубликовано: (2002)

Is It Because I Can or Because of Who I Am?
по: María Laura Gonzalez-Canosa, и др.
Опубликовано: (2021-12-01)

Paradoxical reactions: Under-recognized adverse effects of drugs?
по: Hauben, M, и др.
Опубликовано: (2006)

National differences in publishing papers on adverse drug reactions.
по: Ferner, R, и др.
Опубликовано: (2005)

RMK462 - PENTADBIRAN TANAH FEBRUARI 1998
по: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Опубликовано: (1998)

REG 462 - REKABENTUK KONKRIT JUN 1992
по: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Опубликовано: (1992)

PGT 462: Pengelolaan Dan Penyelidikan Sekolah
по: PPIP, Pusat Pengajian Ilmu Pendidikan
Опубликовано: (1997)

PGT 462 Pengelolaan dan Penyeliaan Sekolah
по: PPIP, Pusat Pengajian Ilmu Pendidikan
Опубликовано: (1997)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
по: Aronson, J
Опубликовано: (2012)

Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016
по: Johanna Seifert, и др.
Опубликовано: (2024-11-01)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
по: Łukasz Dobrek
Опубликовано: (2022-08-01)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
по: Talbot, J, и др.
Опубликовано: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
по: Talbot, J, и др.
Опубликовано: (2012)

SARS-CoV-2 and the role of orofecal transmission: a systematic review
по: Heneghan, CJ, и др.
Опубликовано: (2021)

SARS-CoV-2 and the role of fomite transmission: a systematic review
по: Onakpoya, IJ, и др.
Опубликовано: (2021)